News
Philippines faces risks of limited funding for pandemic response
Philippines faces risks of limited funding for pandemic response
The country remains vulnerable to another surge in COVID-19 cases.
Japan signs deals for vaccine preorders four times the population
The move was lauded as local vaccines remain in Phase II stage.
Swedish firm acquires Singapore-based dialysis clinic chain ARCA
ARCA operates 18 clinics across Singapore and Malaysia.
Healthcare leaders reveal COVID action plans
They mapped out how the industry should respond to the next pandemic during the Healthcare Asia Virtual Conference.
Thailand to become the medicine hub of Southeast Asia
Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.
HSBC releases China pharma market outlook for H2
Small cap companies with low valuations could outperform, but leading companies may provide more stable returns.
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.
Thomson Medical to roll out secure messaging platform
The end-to-end encryption system is expected to protect patient data privacy.
Bumrungrad International Hospital creates first digital microbiology laboratories.
This includes the digitization of its core laboratory, handling 60-70% of its annual tests.
COVID-19 dampens Japan's pharma market
Reduced healthcare spending will affect multinationals' capabilities to launch new products.
Malaysia's ageing population to drive healthcare demand
The country is having high incidence and prevalence of non-communicable diseases.
COVID-19 pushes healthcare sector reform in Pakistan
Poor track record may delay the process despite the government's political will.
Australia healthcare spending signals future growth
High demand is forecasted in the pharmaceuticals industry.
Pandemic to further ramp up healthcare spending in APAC
Countries are declaring fiscal stimulus packages to fight the pandemic.
China's healthcare spending to reach $49b by 2023
By then, China will account for 23% of the world’s healthcare spending.
Private operator Healthscope sells New Zealand pathology business for $364m
Customary approval is expected to be completed within the next six months.
Resource Center
Read Here
Advertise
Sign Up
Event News
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
